EVOTEC/ DE0005664809 /
| 1/22/2025 2:43:15 PM | Chg. - | Volume | Bid5:35:26 PM | Ask5:35:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 8.125EUR | - | 10 Turnover: 79.700 |
-Bid Size: - | -Ask Size: - | 1.4 bill.EUR | - | - |
GlobeNewswire
8/26/2024
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amy...
GlobeNewswire
6/4/2024
QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop f...
GlobeNewswire
6/3/2024
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 T...
GlobeNewswire
6/3/2024
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
5/14/2024
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire
1/16/2024
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...
GlobeNewswire
12/11/2023
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
11/30/2023
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
GlobeNewswire
11/7/2023
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
10/11/2023
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
GlobeNewswire
9/29/2023
Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Ope...
GlobeNewswire
9/14/2023
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September...
GlobeNewswire
9/13/2023
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
GlobeNewswire
3/21/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/17/2022
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financia...
Newsfile Corp
2/17/2022
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Li...
Newsfile Corp
1/26/2022
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a...
GlobeNewswire
1/24/2022
Chinook Therapeutics Announces Appointment of Charlotte Jones-Burton, M.D., M.S. as Senior Vice Pres...
GlobeNewswire
1/10/2022
Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Cent...
GlobeNewswire
1/10/2022
Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Ex...
GlobeNewswire
1/5/2022
Galecto Adds Experienced Biotech Executive Stephanie Oestreich as Chief Business Officer